Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BioLok International was a medical device company focused on the development and commercialization of dental implant systems and reconstructive dental products. The company's core innovation was the Laser-Lok technology, a proprietary laser-ablated surface treatment applied to dental implants to promote the physical attachment of both bone and soft tissue. This technology was designed to prevent crestal bone loss and improve the long-term stability of dental prosthetics. In 2006, BioLok merged with BioHorizons, a move that combined their respective implant technologies and expanded their global market presence in the dental industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BioLok International.